Thinking past the pill: Pfizer is investing heavily in adherence, putting patient support programs on equal footing with some of its drugs, Matthew Arnold reports

Authors :: Arnold, Matthew
Source :: Medical Marketing & Media. October 1, 2010, Vol. 45 Issue 10, p38, 4 p.
Publication Year :: 2010
Abstract: Adherence is a pricey problem. Patients failing to take their meds as directed or at all costs us anywhere from $170 billion to more than a quarter-trillion in added healthcare [...]

Subjects :: Pfizer Inc.
Medical care, Cost of
Health care reform
Patient compliance
Pharmaceutical industry
Business
Health care industry

Tools